Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy
ConclusionOur results elucidated the PBMC single-cell landscape and provided insights into precision medicine and immunotherapy for treating AML.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chemotherapy | Genetics | Immunotherapy | Leukemia | Stem Cell Therapy | Stem Cells | Study